# EDGAR Filing Document

**Accession Number:** 0000787253
**File Stem:** 0001437749-25-037601
**Filing Date:** 2025-12
**Character Count:** 5589
**Document Hash:** 634552df8a65b19789dba49a71853666
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-25-037601.hdr.sgml**: 20251212

**ACCESSION NUMBER**: 0001437749-25-037601

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20251205

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20251212

**DATE AS OF CHANGE**: 20251211

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NATURAL ALTERNATIVES INTERNATIONAL INC
- **CENTRAL INDEX KEY:** 0000787253
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 841007839
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-15701
- **FILM NUMBER:** 251566270

**BUSINESS ADDRESS:**
- **STREET 1:** 1535 FARADAY AVENUE
- **CITY:** CARLSBAD
- **STATE:** CA
- **ZIP:** 92008-7319
- **BUSINESS PHONE:** 7607367700

**MAIL ADDRESS:**
- **STREET 1:** 1535 FARADAY AVENUE
- **CITY:** CARLSBAD
- **STATE:** CA
- **ZIP:** 92008-7319

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AMERICAN ACQUISITIONS INC
- **DATE OF NAME CHANGE:** 19860929

?xml version='1.0' encoding='ASCII'? naii20251212_8k.htm

------

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

------

**FORM 8-K** 

------

**CURRENT REPORT**

**pursuant to Section 13 or 15(d) of the** 

**Securities Exchange Act of 1934** 

**DATE OF REPORT (Date of earliest event reported): December 5, 2025**

**000-15701**

**(Commission file number)** 

------

**NATURAL ALTERNATIVES INTERNATIONAL, INC.**

**(Exact name of registrant as specified in its charter)** 

------

---

| | |
|:---|:---|
| **Delaware** | **84-1007839** |
| **(State of incorporation)** | **(IRS Employer Identification No.)** |
| **1535 Faraday Avenue**<br> **Carlsbad, California 92008** | **(760) 736-7700** |
| **(Address of principal executive offices)** | **(Registrant**'**s telephone number)** |

---

------

---

| | | |
|:---|:---|:---|
| Title of each class | Trading<br> Symbol(s) | Name of each exchange on which registered |
| Common | NAII | NASDAQ |

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

------

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **ITEM 5.07** | **SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.**  |

---

Our Annual Meeting of Stockholders was held on December 5, 2025. The following table sets forth the matters voted upon at the meeting and the results of the voting on each matter voted upon:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Matter Voted Upon** | **Votes For** | **Withheld** | **Votes<br> Against** | **Abstentions** | **Broker<br> Non-Votes** |
| Election of one Class II director to serve until the next annual meeting of stockholders held to elect Class II directors and until such director's successor is elected and qualified: |  |  |  |  |  |
| Alan G Dunn | 3096094 | 132700 |  |  | 1519356 |
| Approval of the First Amendment to the 2020 Omnibus Equity Incentive Plan | 3025686 |  | 195970 | 7138 | 1519356 |
| Ratification of the selection of Haskell & White LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2026 | 4660314 |  | 83683 | 4153 |  |
| To approve, on an advisory, non-binding basis, the compensation of the Company's named executive officers | 3092272 |  | 99248 | 37274 | 1519356 |
| An advisory, non-binding vote regarding the frequency of voting by the stockholders on the executive compensation of the Company's executive officers |  |  |  |  |  |
| One year | 1165476 |  |  |  |  |
| Two years | 20602 |  |  |  |  |
| Three years | 2006157 |  |  |  |  |
| Abstentions and non-votes |  |  |  | 36199 | 1519356 |

---

The election of the one named director, the First Amendment to the 2020 Omnibus Equity Incentive Plan, the Ratification of Haskell & White, the compensation of the named executive officers, and the three-year frequency of non-binding votes on executive compensation were each approved by the stockholders at the annual meeting.

**SIGNATURES** 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Natural Alternatives International, Inc.** | **Natural Alternatives International, Inc.** |
| Date: December 11, 2025 | By: | /s/ Michael E. Fortin |
|  |  | **Michael E. Fortin** |
|  |  | **Chief Financial Officer** |

---